Not logged in.

Please log in or sign up to get more functionality and access your account.

User Log In


×

Forgotten Username

Please provide your e-mail address and we will send the list of all your registered usernames to you...

×

Forgotten Password

Please provide your username and e-mail address and we will send a link to reset your password to your mailbox...

×

User Log Out

Are you sure to log out now?

×
From: 2026-02-27 To: 2026-03-27
HQ Analysis of GERN / RXRX
Symbol Title Sector Industry M.Cap.[M] Div Yield Last Close AvgVol 200d
GERN Geron Corporation Healthcare Biotechnology 897 1.4 10633945
RXRX Recursion Pharmaceuticals Inc Healthcare Biotechnology 1553 2.94 28924416
loading

Orthogonal Spread Analysis

Here we apply an orthogonal regression (also known as total least squares) to both price series. We are interested in some key statistical properties (like β, ...) and in analysing orthogonal residuals:

TLS: GERN*(t) = β * RXRX*(t) + α
Regression coefficient α:
1.425892
Regression coefficient β:
0.038968
Standard Deviation (σ):
0.071651
ADF test of residuals (p-value):
0.2152
95% confidence: residuals seem to contain a unit root
99% confidence: residuals seem to contain a unit root
Mean Reversion Coefficient (MRC):
-0.473667
Half-life:
1.46
Skewness:
-0.3644
Kurtosis:
-0.7166
Doornik-Hansen normality test (p-value):
0.6437
Normality test failed at 95% confidence
0.4785
Normality test failed at 95% confidence
loading

Cointegration Analysis

In this section, Engle-Granger cointegration test is performed using OLS regression method in both directions. Residuals of the regression are plotted and analyzed further:

GERN / RXRX
RXRX / GERN

Profit Analysis

Profit analysis is a set of backtests performed using multiple pair trading models over significant portion of parameter space. Backtest results are displayed in a form of scatter plot. In addition, you can see aggregated statistics in the left panel. All backtests are performed using 100% margin (leverage 1:1). This is the profit analysis where backtested strategies are allowed to open both long and short positions:

GERN / RXRX
RXRX / GERN

This is the profit analysis where backtested strategies are allowed to open long positions only:

GERN / RXRX
RXRX / GERN

This is the profit analysis where backtested strategies are allowed to open short positions only:

GERN / RXRX
RXRX / GERN

Profit Analysis (Inverted!)

This profit analysis has been performed using strategies with inverted signals and transformed prices. Mostly useful for trading pairs composed of an inverse ETF in order to stay market-neutral (more info). "even" means that the first leg is both inverted and transformed, "odd" means that the first leg is transformed but the second leg is inverted.

Backtested strategies have been allowed to open both long and short positions:

GERN / RXRX (even)
GERN / RXRX (odd)
RXRX / GERN (even)
RXRX / GERN (odd)

This is the profit analysis where backtested strategies are allowed to open long positions only:

GERN / RXRX (even)
GERN / RXRX (odd)
RXRX / GERN (even)
RXRX / GERN (odd)

This is the profit analysis where backtested strategies are allowed to open short positions only:

GERN / RXRX (even)
GERN / RXRX (odd)
RXRX / GERN (even)
RXRX / GERN (odd)
FB LN TW

Disclaimer: Backtested, simulated or hypothetical performance results have certain inherent limitations. Unlike the results shown in an actual performance record, these results do not represent actual trading. There are numerous factors related to the stock market in general and to the implementation of any stock market timing program, which cannot be fully accounted for in the preparation of hypothetical performance results. The backtested results listed here do not take into consideration slippage, fees, taxes, or dividends and interest earned on cash positions. These factors would affect actual trading results. Simulated, backtested or hypothetical stock trading systems in general are also subject to the fact that they are designed with the benefit of hindsight. Backtested performance does not represent actual performance and should not be interpreted as an indication of such performance. No representation is being made that you will or is likely to achieve profits or losses similar to these being shown. This site provides impersonal educational stock trading information, and therefore, no consideration can or is made toward your financial circumstances. All material presented within is not to be regarded as investment advice, but for general informational purposes only.